The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Wren Laboratories
Development and validation of a multigenomic liquid biopsy (PROSTest) for prostate cancer detection.
 
Irvin Mark Modlin
Consulting or Advisory Role - Wren Laboratories
 
Mark Kidd
No Relationships to Disclose
 
Ignat A. Drozdov
Consulting or Advisory Role - Wren Laboratories
 
Martin Boegemann
Employment - Janssen; Janssen
Honoraria - Advanced Accelerator Applications; Amgen; Astellas Pharma; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck; MSD; Novartis; Pfizer; Roche; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; ipsen; Janssen-Cilag; Merck; MSD; Novartis; Roche; Sanofi
Research Funding - IPSEN (Inst); Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Bayer; BMS GmbH & Co. KG; Janssen-Cilag
 
Lisa Bodei
Research Funding - AAA/Endocyte/Novartis; AAA/Endocyte/Novartis; Advanced Accelerator Applications/Novartis; Advanced Accelerator Applications/Novartis; ITM Isotope Technologies Munich; Molecular Targeting Technologies
(OPTIONAL) Uncompensated Relationships - AAA/Endocyte/Novartis; Clovis Oncology; IBA RadioPharma Solutions; ITM Isotope Technologies Munich; Molecular Targeting Technologies
 
Jolanta Kunikowska
No Relationships to Disclose
 
Anna Malczewska
No Relationships to Disclose
 
Christof Bernemann
No Relationships to Disclose
 
Kambiz Rahbar
No Relationships to Disclose